Target intelligence / Profile preview

Ribosomal protein L12 pseudogene 32 (RPL12P32)

Target
RPL12P32
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L12 pseudogene 32 (RPL12P32) is a processed pseudogene in the human genome related to the functional RPL12 gene, which encodes a component of the large (60S) subunit of the ribosome. As a pseudogene, RPL12P32 does not code for a functional protein and is not known to have a biological function, role in disease, or relevance as a therapeutic target. It may have arisen through gene duplication or retrotransposition events and is catalogued alongside several other RPL12-derived pseudogenes in the human genome. RPL12P32 is listed as a pseudogene, not a protein-coding or functional gene, and does not produce a protein product. Pseudogenes are generally considered non-functional genomic elements, often remnants of once-functional genes that have lost coding potential due to mutations or truncations; thus, they are not therapeutic targets. This entry is not a valid drug target; it is a non-coding sequence with no associated protein, function, or pathology. The actual, functional gene is RPL12 (Ribosomal protein L12), which encodes a ribosomal structural protein of the 60S subunit, but RPL12P32 itself is not involved in any known cellular function, diseases, or therapeutics. There are several similar pseudogenes for ribosomal proteins catalogued in the human genome with analogous nomenclature (RPL12P1, RPL12P2, etc.).

Other names
RPL12_12_1226

Beyond the preview

Go deeper on Ribosomal protein L12 pseudogene 32 (RPL12P32).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L12 pseudogene 32 (RPL12P32).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call